Guillaume Beinse

5PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 15, 2026
ctDNA for Prognostication and Monitoring in Patients with Metastatic Endometrial Carcinoma Treated with Olaparib: Validation in the GINECO-UTOLA Trial.

Guillaume Beinse, Valerie Taly, Alexandra Leary

|Jan 08, 2026
ESR1 Mutation in Endocrine Treatment-Naïve Endometrial Cancer: Prevalence, Characteristics, and Prognostic Implications, Results from the UTOLA Phase II GINECO Trial.

Félix Blanc-Durand, Catherine Genestie, Sergey Nikolaev

|Jul 08, 2025
Droplet Digital PCR Assay for Detection and Monitoring of Universally Methylated ctDNA in Patients with Sarcoma.

Elisabeth Ashton, Valérie Taly, Camille Tlemsani

|Apr 14, 2025
Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis.

Julie Berthet, Amel Kime, Bruno Borghese

|Mar 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.

Guillaume Beinse, Pierre-Alexandre Just, Bastien Rance

Pageof 1

Frequent Collaborators

4 joint publications

Jerome Alexandre

2 joint publications

Coriolan Lebreton

2 joint publications

Pierre-Emmanuel Brachet

2 joint publications

Pierre Fournel